INIFY Laboratories AB (OSL:INIFY)
Norway · Delayed Price · Currency is NOK 8.00
+0.10 (1.27%)
At close: Jul 14, 2026
INIFY Laboratories AB Market Cap
INIFY Laboratories AB has a market cap or net worth of 859.8 million as of July 15, 2026. Its market cap has increased by 65.10% in one year.
Market Cap
859.80M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
8.00
Market Cap Chart
Since June 20, 2022, INIFY Laboratories AB's market cap has increased from 452.37M to 859.80M, an increase of 90.07%. That is a compound annual growth rate of 17.10%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 14, 2026 | 859.80M | 125.14% |
| Dec 30, 2025 | 381.89M | 1.25% |
| Dec 30, 2024 | 377.20M | -32.76% |
| Dec 29, 2023 | 560.94M | 72.20% |
| Dec 30, 2022 | 325.75M | -27.99% |
| Jun 20, 2022 | 452.37M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medistim ASA | 4.28B |
| Circio Holding ASA | 1.79B |
| Nordhealth AS | 1.75B |
| Thor Medical ASA | 1.56B |
| ArcticZymes Technologies ASA | 967.80M |
| Nykode Therapeutics AS | 917.60M |
| Vistin Pharma ASA | 900.20M |
| Omda AS | 742.38M |